Browsing by Contributors Floege, Jürgen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 11 of 11
PreviewIssue DateTitleContributor(s)
2016 NDT Volume 31 Issue 11 November (24).pdf.jpg2016Con: STOP immunosuppression in IgA nephropathy.Rauen, Thomas; Eitner, Frank; Fitzner, Christina; Floege, Jürgen; Pozzi, Claudio
441-51.pdf.jpgMar-2015Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohortTitze, Stephanie; Schmid, Matthias; Köttgen, Anna; Busch, Martin; Floege, Jürgen; Wanner, Christoph; Kronenberg, Florian; Eckardt, Kai-Uwe
288-93.pdf.jpgFeb-2015High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD studyDrechsler, Christiane; Evenepoel, Pieter; Vervloet, Marc G; Wanner, Christoph; Ketteler, Markus; Marx, Nikolaus; Floege, Jürgen; Dekker, Friedo W; Brandenburg, Vincent M
1542.pdf.jpgSep-2015Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS studyFernández-Martín, José Luis; Martínez-Camblor, Pablo; Dionisi, María Paula; Floege, Jürgen; Ketteler, Markus; London, Gérard; Locatelli, Francesco; Gorriz, José Luis; Rutkowski, Boleslaw; Ferreira, Aníbal; Bos, Willem-Jan; Covic, Adrian; Rodríguez-García, Minerva; Sánchez, José Emilio; Rodríguez-Puyol, Diego; Cannata-Andia, Jorge B
2016 NDT Volume 31 Issue 8 August (4).pdf.jpg2016Lack of evidence does not justify neglect : how can we address unmet medical needs in calciphylaxis ?Brandenburg, Vincent M; Evenepoel, Pieter; Floege, Jürgen; Goldsmith, David; Kramann, Rafael; Massy, Ziad; Mazzaferro, Sandro; Schurgers, Leon J; Sinha, Smeeta; Torregrosa, Vicens
1037.pdf.jpgJun-2015Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patientsFloege, Jürgen; Covic, Adrian C; Ketteler, Markus; Mann, Johannes F E; Rastogi, Anjay; Spinowitz, Bruce; Chong, Edward M F; Gaillard, Sylvain; Lisk, Laura J; Sprague, Stuart M
2016 NDT Volume 31 Issue 2 February (7).pdf.jpg2016NDT Perspectives Highlights of the 2015 ERA-EDTA Congress — glomerular diseasesFloege, Jürgen
2016 Lancet Volume 387 Issue 10032 May (5).pdf.jpg2016Primary glomerulonephritidesFloege, Jürgen; Amann, Kerstin
2132.pdf.jpgAug-2015Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosisBoor, Peter; Bábíčková, Janka; Steegh, Floor; Hautvast, Petra; Martin, Ina V; Djudjaj, Sonja; Nakagawa, Taizo; Ehling, Josef; Gremse, Felix; Bücher, Eva; Eriksson, Ulf; van Roeyen, Claudia R C; Eitner, Frank; Lammers, Twan; Floege, Jürgen; Peutz-Kootstra, Carine J; Ostendorf, Tammo
1112.pdf.jpgJul-2015Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseasesPapasotiriou, Marios; Genovese, Federica; Klinkhammer, Barbara M; Kunter, Uta; Nielsen, Signe H; Karsdal, Morten A; Floege, Jürgen; Boor, Peter
2016 NDT Volume 31 Issue 1 January (20).pdf.jpg2016Vascular calci fi cation in chronic kidney disease : an updateSchlieper, Georg; Schurgers, Leon; Brandenburg, Vincent; Reutelingsperger, Chris; Floege, Jürgen